daawaynta caabuqyada degdega ah ee corona by...?
daawaynta caabuqyada degdega ah ee corona by...?
Tijaabo caafimaad, oo natiijooyinkeeda la daabacay, Arbacadii, joornaal caafimaad oo gaar ah, ayaa muujisay in dawada "tofacitinib" ee daaweynta arthritis-ku ay muujisay natiijooyin rajo leh oo ku saabsan daaweynta bukaannada leh calaamadaha daran ee cudurka Covid-19.
Tijaabada caafimaad, oo natiijadii lagu daabacay "Journal New England Journal of Medicine," ayaa ka dhacday 289 qof oo lagu daweynayay isbitaallo ku yaal 15 goobood oo kala duwan oo Brazil ah sababo la xiriira calaamadaha daran ee Covid-19.
Kala badh ka mid ah bukaannadan ayaa la siiyay tofacitinib (laba kiniin ah 10 mg maalintii) oo lagu daray daryeelka caafimaadka caadiga ah iyo qaybta kale waxaa la siiyay placebo leh daryeel caafimaad oo isku mid ah.
28 maalmood ka dib, 18% kooxda dawada heshay ayaa midkood uu ku dhacay neef-mareenka (tusaale u baahan in la xidho ama la galo qalabka neefsiga) ama ay dhinteen, marka la barbardhigo 29% kooxda placebo.
Dhammaan, 5.5% bukaannada placebo ayaa dhintay, marka la barbardhigo 2.8% kooxda tofacitinib.
Tofacitinib waxaa lagu suuq geeyaa noocyo kala duwan, oo ay ku jiraan Zeljans, oo ay leedahay kooxda dawooyinka Mareykanka ee Pfizer.
Otavio Berwanger, oo ah dhakhtar ka tirsan cisbitaalka Albert Einstein ee Israa'iil oo sameeyay tijaabada caafimaad isagoo kaashanaya Pfizer ayaa yidhi: "Waxaa nagu dhiirigelinaya natiijooyinka bilowga ah ee tijaabadii aan kala sooc lahayn ee tofacitinib ee bukaannada isbitaallada la dhigay oof wareenka uu sababay Covid-19.
Tofacitinib ayaa loo oggolaaday in lagu isticmaalo gudaha Maraykanka si loogu daweeyo rheumatoid arthritis-ka, psoriatic arthritis, iyo colitis boog-boog.
Mawduucyo kale: